Bruce, Jeff P.
To, Ka-Fai http://orcid.org/0000-0003-4919-3707
Lui, Vivian W. Y. http://orcid.org/0000-0001-6918-1573
Chung, Grace T. Y.
Chan, Yuk-Yu
Tsang, Chi Man
Yip, Kevin Y. http://orcid.org/0000-0001-5516-9944
Ma, Brigette B. Y. http://orcid.org/0000-0003-4802-1102
Woo, John K. S.
Hui, Edwin P. http://orcid.org/0000-0002-8134-7019
Mak, Michael K. F.
Lee, Sau-Dan
Chow, Chit http://orcid.org/0000-0002-2364-8331
Velapasamy, Sharmila
Or, Yvonne Y. Y.
Siu, Pui Kei
El Ghamrasni, Samah http://orcid.org/0000-0003-4346-1360
Prokopec, Stephenie http://orcid.org/0000-0001-7936-8577
Wu, Man
Kwan, Johnny S. H.
Liu, Yuchen http://orcid.org/0000-0002-7647-6481
Chan, Jason Y. K. http://orcid.org/0000-0002-9480-4637
van Hasselt, C. Andrew
Young, Lawrence S. http://orcid.org/0000-0003-3919-4298
Dawson, Christopher W.
Paterson, Ian C. http://orcid.org/0000-0001-9156-401X
Yap, Lee-Fah http://orcid.org/0000-0002-6815-3607
Tsao, Sai-Wah
Liu, Fei-Fei
Chan, Anthony T. C.
Pugh, Trevor J. http://orcid.org/0000-0002-8073-5888
Lo, Kwok-Wai http://orcid.org/0000-0002-3488-6124
Article History
Received: 6 October 2020
Accepted: 19 May 2021
First Online: 7 July 2021
Change Date: 27 July 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-022-32156-9
Competing interests
: All authors declare no competing interests directly related to the current study. V.W.Y. Lui receives funding from a University-Industry Collaboration Program (UIM/329) by the Innovation and Technology Fund, Hong Kong government, and Lee’s Pharmaceutical (Hong Kong Limited) for the period of 2018–2020, and also served as a scientific consultant for Novartis Pharmaceutical (Hong Kong) Limited (Oct 2015-Oct 2016). B.B.Y. Ma received speaker’s honorarium and serves in the advisory board of Bristol-Myers Squibb (BMS), MSD and Novartis, Hong Kong. She has received a research grant from Novartis and Boerhinger Ingelheim. E.P. Hui received speaker’s honoraria and serves in the advisory board of Merck Sharp & Dohme (MSD) and Merck Serono. A.T.C. Chan received research and travel grants from MSD, Pfizer, and Roche. The other authors declare no competing interests.